Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells.

Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Abstract Text:

    kolja gelseKolja Gelse,klaus von der markKlaus von der Mark,thomas aignerThomas Aigner,jung parkJung Park,holm schneiderHolm Schneider,

    OBJECTIVE: To investigate the repair of partial-thickness lesions in rat articular cartilage by combining cell transplantation with transfer of growth factor complementary DNA (cDNA). METHODS: Mesenchymal cells isolated from rib perichondrium were infected ex vivo with adenoviral vectors carrying bone morphogenetic protein 2 (BMP-2) or insulin-like growth factor 1 (IGF-1) cDNA. The cells were suspended in fibrin glue and applied to mechanically induced partial-thickness cartilage lesions in the patellar groove of the rat femur. The filling of the defects was quantified and the quality and integration of the newly formed tissue were assessed by histochemical and immunohistochemical methods. Uninfected cells or cells infected with a LacZ reporter gene vector served as controls. RESULTS: Transplanted cells were able to attach to the wounded articular cartilage and were not displaced from the lesions by joint movement. Cells infected with both adenoviral vectors AdBMP-2 and AdIGF-1 produced repair cartilage of hyaline morphology containing a type II collagen-positive but type I collagen-negative proteoglycan-rich matrix that restored the articular surface in most lesions. Uninfected cells either failed to fill up the defects or formed fibrous tissue mainly composed of type I collagen. Excessive cells were partially dislocated to the joint margins, leading to osteophyte formation there if AdBMP-2-infected cells were used. These adverse effects, however, were not seen with AdIGF-1-infected cells. CONCLUSION: Stimulation of perichondrium-derived mesenchymal cells by transfer of growth factor cDNA in a partial-thickness defect model allows for satisfactory cartilage restoration by a repair tissue comparable with hyaline articular cartilage.

    Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Publishing Authors By Initials

    k gelseK Gelse,k von der markK von der Mark,t aignerT Aigner,j parkJ Park,h schneiderH Schneider,

    For similar biological phenomena, cell phenomena, and immunity: biological phenomena: regeneration: wound healing research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: regeneration: wound healing research

    PUBMED ID PMID:

    MEDLINE DATE:

    Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Arthritis and rheumatism

    VOLUME: 48

    Page Numbers: 430-41

    Journal Abbreviation: Arthritis Rheum.

    ISSN: 0004-3591

    DAY: 19

    MONTH: Feb

    YEAR: 2003

    Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370605

    Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Keywords Mesh Terms:

    KEYWORDS: Wound Healing

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Information

    Substance Name: Insulin-Like Growth Factor I

    Registry Number: 67763-96-6

    Grant and Affiliation Information for Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells.

    AFFILIATION: University of Erlangen-Nuernberg, Erlangen, Germany.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arthritis Rheum

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News